Stay updated on Dupilumab in ABPA Treatment Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference3%
- Check19 days agoChange DetectedAdds Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and Revision: v3.0.2; overall, updates versioning and trims older topics.SummaryDifference0.4%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision updated to v3.0.2 and 'Back to Top' link removed.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as important topics related to drug safety and counterfeit drugs. Notably, the previous mentions of specific locations and terms have been removed.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.